A promoter genotype and oxidative stress potentially link resistin to human insulin resistance

被引:139
作者
Smith, SR [1 ]
Bai, FL [1 ]
Charbonneau, C [1 ]
Janderová, L [1 ]
Argyropoulos, G [1 ]
机构
[1] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA
关键词
D O I
10.2337/diabetes.52.7.1611
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin resistance is a component of type 2 diabetes and often precedes pancreatic beta-cell failure. Contributing factors include obesity and a central pattern of fat accumulation with a strong genetic component. The adipocyte secreted hormone resistin has been proposed as a link between the adipocyte and insulin resistance by inhibition of insulin-stimulated glucose uptake and/or blocking adipocyte differentiation. Here we report that the G/G genotype of a single nucleotide polymorphism (SNP) in the promoter of the human resistin gene, -180C>G, had significantly increased basal promoter activity in adipocytes. These data were recapitulated in vivo, where G/G homozygotes had significantly higher resistin mRNA levels in human abdominal subcutaneous fat. A significant interaction was also found between the -180C>G SNP, a marker of oxidative stress (NAD[P]H quinone oxidoreductase mRNA) and homeostasis model assessment of insulin resistance. In addition, resistin mRNA was positively and independently correlated with insulin resistance and hepatic fat as measured by liver X-ray attenuation. These data implicate resistin in the pathophysiology of the human insulin resistance syndrome, an effect mediated by the -180C>G promoter SNP and potentially cellular oxidative stress.
引用
收藏
页码:1611 / 1618
页数:8
相关论文
共 41 条
  • [11] Regulation of genes encoding NAD(P)H:quinone oxidoreductases
    Jaiswal, AK
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2000, 29 (3-4) : 254 - 262
  • [12] Jonke J, 2002, OBES RES, V10, P1
  • [13] The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on oxidative enzymes in adipocytes and liver
    Kern, PA
    Fishman, RB
    Song, W
    Brown, AD
    Fonseca, V
    [J]. TOXICOLOGY, 2002, 171 (2-3) : 117 - 125
  • [14] Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and β-arrestins
    Kim, KM
    Valenzano, KJ
    Robinson, SR
    Yao, WD
    Barak, LS
    Caron, MG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (40) : 37409 - 37414
  • [15] Le Lay S, 2001, BIOCHEM BIOPH RES CO, V289, P564, DOI 10.1006/bbrc.2001.6015
  • [16] Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians
    Ma, XW
    Warram, JH
    Trischitta, V
    Doria, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09) : 4407 - 4410
  • [17] HOMEOSTASIS MODEL ASSESSMENT - INSULIN RESISTANCE AND BETA-CELL FUNCTION FROM FASTING PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS IN MAN
    MATTHEWS, DR
    HOSKER, JP
    RUDENSKI, AS
    NAYLOR, BA
    TREACHER, DF
    TURNER, RC
    [J]. DIABETOLOGIA, 1985, 28 (07) : 412 - 419
  • [18] A role for the Agouti-Related Protein promoter in obesity and type 2 diabetes
    Mayfield, DK
    Brown, AM
    Page, GP
    Garvey, WT
    Shriver, MD
    Argyropoulos, G
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 287 (02) : 568 - 573
  • [19] Resistin, central obesity, and type 2 diabetes
    McTernan, CL
    McTernan, PG
    Harte, AL
    Levick, PL
    Barnett, AH
    Kumar, S
    [J]. LANCET, 2002, 359 (9300) : 46 - 47
  • [20] Morin N, 2001, J PHARMACOL EXP THER, V297, P563